Integrated Research Limited (ASX:IRI)
Australia · Delayed Price · Currency is AUD 0.3400
+0.0050 (1.49%)
Aug 28, 2026, 4:10 PM AEST
Integrated Research Income Statement
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
| 57.64 | 68.26 | 83.29 | 69.83 | 62.87 | |
Revenue Growth | -15.56% | -18.05% | 19.28% | 11.07% | -19.91% |
Gross Profit | 57.64 | 68.26 | 83.29 | 69.83 | 62.87 |
Selling, General & Admin | 41.43 | 41.37 | 45.17 | 47.2 | 47.38 |
Research & Development | 17.39 | 13.51 | 12.78 | 23.7 | 22.77 |
Operating Expenses | 58.82 | 54.89 | 57.95 | 70.9 | 70.14 |
Operating Income | -1.19 | 13.37 | 25.34 | -1.07 | -7.28 |
Interest Expense | -0.1 | -0.1 | -0.1 | -0.07 | -0.23 |
Interest & Investment Income | 3.65 | 3.06 | 2.32 | 2.24 | 2.05 |
Currency Exchange Gain (Loss) | -2.69 | 0.52 | -0.94 | 0.85 | 1.64 |
Other Non Operating Income (Expenses) | 1.02 | 0.35 | 0.09 | 0.53 | - |
EBT Excluding Unusual Items | 0.7 | 17.2 | 26.71 | 2.48 | -3.81 |
Impairment of Goodwill | - | - | - | -3.73 | - |
Gain (Loss) on Sale of Assets | 0.04 | 1.22 | - | - | - |
Asset Writedown | - | - | - | -28.05 | - |
Other Unusual Items | - | - | - | - | 1.36 |
Pretax Income | 0.74 | 18.42 | 26.71 | -29.3 | -2.45 |
Income Tax Expense | -0.47 | 5.06 | -0.42 | -0.07 | -3.99 |
Net Income | 1.21 | 13.36 | 27.13 | -29.23 | 1.55 |
Net Income to Common | 1.21 | 13.36 | 27.13 | -29.23 | 1.55 |
Net Income Growth | -90.94% | -50.76% | - | - | -80.53% |
Shares Outstanding (Basic) | 180 | 177 | 174 | 173 | 172 |
Shares Outstanding (Diluted) | 182 | 180 | 179 | 173 | 173 |
Shares Change | 1.13% | 0.60% | 3.39% | 0.01% | 0.17% |
EPS (Basic) | 0.01 | 0.08 | 0.16 | -0.17 | 0.01 |
EPS (Diluted) | 0.01 | 0.07 | 0.15 | -0.17 | 0.01 |
EPS Growth | -90.98% | -51.05% | - | - | -80.65% |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Free Cash Flow | 12.39 | 8.18 | 13 | 13.51 | 16.64 |
Free Cash Flow Per Share | 0.07 | 0.04 | 0.07 | 0.08 | 0.10 |
Dividend Per Share | 0.030 | 0.020 | 0.020 | - | - |
Dividend Growth | 50.00% | 0% | - | - | - |
Gross Margin | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
Operating Margin | -2.06% | 19.59% | 30.42% | -1.53% | -11.58% |
Profit Margin | 2.10% | 19.57% | 32.57% | -41.85% | 2.46% |
Free Cash Flow Margin | 21.50% | 11.99% | 15.60% | 19.34% | 26.47% |
EBITDA | -0.99 | 13.45 | 25.35 | -0.73 | -6.63 |
EBITDA Margin | -1.72% | 19.71% | 30.43% | -1.04% | -10.55% |
D&A For EBITDA | 0.19 | 0.08 | 0 | 0.34 | 0.65 |
EBIT | -1.19 | 13.37 | 25.34 | -1.07 | -7.28 |
EBIT Margin | -2.06% | 19.59% | 30.42% | -1.53% | -11.58% |
Effective Tax Rate | - | 27.49% | - | - | - |
Revenue as Reported | 57.64 | 68.26 | 83.29 | 69.83 | 62.87 |